Entry Point Capital, LLC Harrow Health, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 6,398 shares of HROW stock, worth $308,639. This represents 0.2% of its overall portfolio holdings.
Number of Shares
6,398
Previous 1,883
239.78%
Holding current value
$308,639
Previous $24.9 Million
436.5%
% of portfolio
0.2%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding HROW
# of Institutions
135Shares Held
20MCall Options Held
700KPut Options Held
564K-
Opaleye Management Inc. Boston, MA3.99MShares$192 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$131 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$104 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$88.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$34.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.31B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...